Original Articles

Comparison of Oral (Prednisolone) Versus Intravenous (Hydrocortisone) Steroids in Acute Exacerbation of Bronchial Asthma in Hospitalized Patients

  1. Allied II Hospital, Faisalabad Medical University
  2. Consultant Pulmonologist, DHQ Hospital Vehari
  3. Professor of Pulmonology & Critical Care, Islamic International University, Riphah Hospital
  4. Post Graduate Resident, Allied II Hospital, Faisalabad Medical University
https://doi.org/10.48036/apims.v20i4.1347

Abstract

Objective: To compare the efficacy of oral versus intravenous corticosteroids in improving peak expiratory flow (PEF) in patients admitted with acute exacerbation of asthma.

Methodology: This randomized controlled trial was conducted from October 17, 2018, to April 16, 2019, at the Department of Pulmonology, PIMS, Islamabad. A total of 166 patients (18–65 years, both genders) with a documented history of bronchial asthma presenting with acute exacerbation were enrolled. Patients were randomly assigned to Group A (intravenous hydrocortisone 100 mg every 8 hours for 72 hours) or Group B (oral prednisolone 60 mg once daily for 72 hours). Both groups received standard bronchodilator therapy with nebulized salbutamol 2.5 mg/2.5 ml four times daily and as needed. PEF was measured before and after salbutamol at baseline, every 6 hours for 72 hours, and twice daily until discharge. The percentage change in PEF from baseline was assessed at 72 hours and compared using an independent sample t-test.

Results: At baseline, mean PEF was 409.3 ± 65.4 L/min in Group A and 408.7 ± 69.2 L/min in Group B (p=0.956). After 72 hours, PEF improved to 545.3 ± 64.4 L/min in Group A and 539.7 ± 67.2 L/min in Group B (p=0.594). The mean percentage change in PEF was 34.2% ± 6.4 in Group A and 33.1% ± 6.5 in Group B (p=0.274).

Conclusion: Oral corticosteroids were found to be equally effective as intravenous corticosteroids in treating acute asthma exacerbations. Given their cost-effectiveness, ease of administration, and patient comfort, oral corticosteroids should be preferred whenever possible.

Author Biography

  • Saif Ur Rahman, Allied II Hospital, Faisalabad Medical University

    Consultant Pulmonologist, Department of Pulmonology, ALLIED II Hospital, Faisalabad Medical University

Metrics

1,706Abstract views
1,293Downloads

Full Text

License

Copyright (c) 2024 Saif Ur Rahman, Muhammad Tahir Jillani, Rubina Aman, Usman Khalid, Muhammad Naveed Abbas, Huzaifa Naeem

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0/.) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More in this Issue